ArticleClinical & translational immunology2021

Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy.

Mohamed Shanavas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.